<DOC>
	<DOCNO>NCT01557036</DOCNO>
	<brief_summary>The primary objective study expand body clinical knowledge patient undergoing Pipeline Embolization Device ( Pipeline PED ) placement intracranial aneurysm ( IAs ICAs ) accord Pipeline 's labeled indication .</brief_summary>
	<brief_title>Aneurysm Study Pipeline Observational Registry</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>( All site , All country ) 1 . At least 1 Pipeline place treatment ICA 2 . Patient patient 's Legally Authorized Representative ( LAR ) sign IRB ECapproved inform consent form , require 3 . Patient willing able comply followup visit United States : Additional Inclusion Criteria subject enrol United States : 4US ) Subjects age 22 high 5US ) IA least 10 mm maximum dimension along internal carotid artery petrous superior hypophyseal segment Canada : Additional Inclusion Criteria subject enrol Canada : 4C ) In Canada , Pipelineâ„¢ Embolization Device intend use without embolic coil treatment complex intracranial aneurysm amenable treatment surgical clipping . 5C ) Canadian licensing/approval limit device 3.25 mm 5.00 mm diameter . France : Additional Inclusion Criteria subject enrol France : 4F ) Unruptured IA , saccular fusiform aneurysm sac diameter &gt; 15mm treatable current therapy ( EVT coil without assist system ( intracranial stent ) balloon remodel , surgery ) due specific morphology . 5F ) IA previously treat unruptured recanalization aneurismal sac &gt; 7 mm , treatable conservative treatment . ( base contraindication PED IFU ) 1 . Active bacterial infection 2 . A patient dual antiplatelet therapy ( aspirin clopidogrel ) contraindicate 3 . A patient receive dual antiplatelet agent prior procedure 4 . Preexisting stent place parent artery target aneurysm location 5 . Angiography demonstrate inappropriate anatomy , e.g. , severe preor postaneurysm narrow 6 . Acutely ruptured aneurysm , defined rupture target aneurysm Each site refer country specific Instructions Use/Approval ( France ) determine final eligibility ASPIRe Registry .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Brain Aneurysm</keyword>
</DOC>